Skip to main content

Advertisement

Log in

Carcinoid Syndrome Misdiagnosed as a Malabsorptive Syndrome after Biliopancreatic Diversion

  • Case Report
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

A case is reported of a woman who developed untreatable diarrhea after a prior biliopancreatic diversion (BPD), attributed to the malabsorptive component. Abdominal ultrasound incidentally found focal liver lesions. On fine needle aspiration biopsy, atypia was found, and these hepatic lesions were resected with free margins. The specimen showed liver metastases of an aggressive malignant neuroendocrine neoplasm. The primary site was subsequently identified to be in the pancreas. The physician and surgeon must realize that non-related diseases can develop after bariatric surgery, as in the general population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003; 289: 187–93.

    Article  PubMed  Google Scholar 

  2. Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005; 6: 283–96.

    Article  PubMed  CAS  Google Scholar 

  3. Adami HO, Trichopoulos D. Obesity and mortality from cancer. N Engl J Med 2003; 348: 1623–4.

    Article  PubMed  Google Scholar 

  4. Alvarez GC, Faria EN, Beck DT et al. Laparoscopic spleen preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obes Surg 2007; 17: 550–2.

    Article  PubMed  Google Scholar 

  5. Valverde I, Puente J, Martin-Duce A et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg 2005; 15: 387–97.

    Article  PubMed  Google Scholar 

  6. Scopinaro N, Gianetta E, Civalleri D et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618–20.

    Article  PubMed  CAS  Google Scholar 

  7. Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion. World J Surg 1998; 22: 936–46.

    Article  PubMed  CAS  Google Scholar 

  8. DeRoover A, Detry O, Desaive C et al. Risk of upper gastrointestinal cancer after bariatric operations. Obes Surg 2006; 16: 1656–61.

    Article  Google Scholar 

  9. Keshishian A, Hamilton J, Hwang L et al. Carcinoid tumor and bariatric surgery. Obes Surg 2002; 12: 874–5.

    Article  PubMed  Google Scholar 

  10. Service GJ, Thompson GB, Service FJ et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005; 353: 249–54.

    Article  PubMed  CAS  Google Scholar 

  11. Cummings DE. Gastric bypass and nesidioblastosis – too much of a good thing for islets? N Engl J Med 2005; 353: 300–2.

    Article  PubMed  CAS  Google Scholar 

  12. Lamounier RN, Pareja JC, Tambascia MA et al. Incretins: clinical physiology and bariatric surgery – correlating the entero-endocrine system and a potentially anti-dysmetabolic procedure. Obes Surg 2007; 17: 569–76.

    Article  PubMed  Google Scholar 

  13. Stewart ID, Flaks B, Watanapa P et al. Pancreatobiliary diversion enhances experimental pancreatic carcinogenesis. Br J Cancer 1991; 63: 63–6.

    PubMed  CAS  Google Scholar 

  14. Watanapa P, Efa EF, Beardshall K et al. Inhibitory effect of a cholecystokinin antagonist on the proliferative response of the pancreas to pancreatobiliary diversion. Gut 1991; 32: 1049–51.

    Article  PubMed  CAS  Google Scholar 

  15. Morisset J, Julien S, Laine J. Localization of cholecystokinin receptor subtypes in the endocrine pancreas. J Histochem Cytochem 2003; 51: 1501–13.

    PubMed  CAS  Google Scholar 

  16. Howatson AG, Carter DC. Pancreatic carcinogenesisenhancement by cholecystokinin in the hamster-nitrosamine model. Br J Cancer 1985; 51: 107–14.

    PubMed  CAS  Google Scholar 

  17. Smith JP, Kramer ST, Solomon TE. CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. Regul Pept 1991; 32: 341–9.

    Article  PubMed  CAS  Google Scholar 

  18. Reubi JC. CCK receptors in human neuroendocrine tumors: clinical implications. Scand J Clin Lab Invest Suppl 2001; 234: 101–4.

    PubMed  CAS  Google Scholar 

  19. Holdstock C, Engstrom BE, Ohrvall M et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003; 88: 3177–83.

    Article  PubMed  CAS  Google Scholar 

  20. Adami GF, Cordera R, Andraghetti G et al. Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. Obes Res 2004; 12: 684–7.

    Article  PubMed  CAS  Google Scholar 

  21. Volante M, Allia E, Gugliotta P et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002; 87: 1300–8.

    Article  PubMed  CAS  Google Scholar 

  22. Zagury L, Moreira RO, Guedes EP et al. Insulinoma misdiagnosed as dumping syndrome after bariatric surgery. Obes Surg 2004; 14: 120–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. M. López-Tomassetti Fernández MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

López-Tomassetti Fernández, E.M., González, I.A., Luis, H.D. et al. Carcinoid Syndrome Misdiagnosed as a Malabsorptive Syndrome after Biliopancreatic Diversion. OBES SURG 17, 989–992 (2007). https://doi.org/10.1007/s11695-007-9157-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-007-9157-4

Key words

Navigation